3
Announcements
Trials
Browse
Landscape
Sponsor
Cancer Type
Lymphoid
31
Breast
29
Other hematologic neoplasm
12
Thoracic
11
Genitourinary
8
Gynecologic
7
Gastrointestinal
5
Sarcoma
4
Tumor-Agnostic
3
Plasma cell
3
Head & Neck
3
CNS
3
Classical hematology
2
Other
1
Endocrine
1
Interventions
Everolimus
18
lanreotide
7
Octreotide
7
pembrolizumab
6
Sunitinib
6
Magnetic Resonance Spectroscopy
5
lutetium Lu 177 dotatate
4
gallium Ga 68 dotatate
4
cabozantinib
4
Nivolumab
4
Carboplatin
4
telotristat ethyl
3
pasireotide
3
lenvatinib
3
arginyllysine
3
Temozolomide
3
Specimen Handling
3
Etoposide
3
Erlotinib Hydrochloride
3
Bevacizumab
3
surufatinib
2
pazopanib
2
amino-acid, glucose, and electrolyte solution
2
X-Rays
2
Sorafenib
2
Phantoms, Imaging
2
Paclitaxel
2
Oxaliplatin
2
Ipilimumab
2
Doxorubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
pegfilgrastim
×
NET
×
Clear all
No trials found.